When was Range Bio founded?

Range Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Where is Range Bio located?

Range Bio is headquartered in San Carlos, United States.

Who is the current CEO of Range Bio?

Brandon Wilson of Range Bio. They have also founded 1 company.

How many employees does Range Bio have?

As of May 31, 2026, the latest employee count at Range Bio is 10.

Is Range Bio a funded company?

Range Bio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 12, 2023.

When was the latest funding round of Range Bio?

Range Bio's latest funding was a $***** Seed round on Jun 12, 2023, with participation from 7 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $3.48B in funding in 2026 to date.

Where does Range Bio rank among its competitors?

Range Bio ranks 3rd amongst 21 active competitors, of which 5 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Biomarx, which secured $942K in Jan, 2026.

Who are the top competitors of Range Bio?

Range Bio's top competitors include Atrys, Nanopath and OrigiMed. Among them, Biomarx secured the most recent funding round in January, 2026.

Range Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of solutions for health monitoring based on translational proteomics. It develops tools that capture the molecular state of individuals to prevent disease and improve health.

Key Metrics

Founded Year

2022

Location

San Carlos, United States

Stage

Seed

Total Funding

$5.2M in 1 round

Latest Funding Round

Seed, Jun 12, 2023, $*****

Investors

Artis Ventures & 6 more

Ranked

3^rd among 21 active competitors

Employee Count

10 as on May 31, 2026

Similar Companies

Atrys & 23 more

View Range Bio's full profile

Range Bio has raised a total funding of $5.2M over 1 round. Its latest funding round was a Seed round on Jun 12, 2023 for $*****. 7 investors participated in its latest round. Range Bio has 7 institutional investors.

Here is the list of recent funding rounds of Range Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 12, 2023	5847489	Seed	2370405	9295319	8928479	8071673

Access funding benchmarks and valuations. Sign up today!

View details of Range Bio's funding rounds and investors

The founders of Range Bio are Brandon Wilson and Nicolo Maganzini. Brandon Wilson is the CEO of Range Bio.

Here are the details of Range Bio's key team members:

Brandon Wilson: Co-Founder & CEO of Range Bio.
Contact Info: 1 email address
Nicolo Maganzini: Co-Founder of Range Bio.

View details of Range Bio's Founder profiles and Board Members

Range Bio's employee count trend

Range Bio has 10 employees as of May 26. Here is Range Bio's employee count trend over the years:

Uncover Range Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Range Bio include Atrys, Nanopath and OrigiMed. Here is the list of Top 10 competitors of Range Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Atrys 2007, Barcelona (Spain), Public	Provider of diagnostic and therapeutic services catering to cancer	-	Deutsche Bank, ING & 4 others	64/100
2nd	Nanopath 2019, Cambridge (United States), Series A	Provider of point-of-care molecuolar diagnostic platform for womens health	$10M	Medtech Convergence Fund, Norwest & 7 others	48/100
3rd	Range Bio 2022, San Carlos (United States), Seed	Provider of solutions for health monitoring based on translational proteomics	$5.2M	Artis Ventures, Four Cities Capital & 5 others	42/100
4th	OrigiMed 2016, Shanghai (China), Series B	Genetics-based personalized cancer counseling	$10M	Grand Flight Investment, IDG Capital & 4 others	39/100
5th	N-of-One 2008, Lexington (United States), Acqui-Hired	NGS analysis, interpretation, and reporting solutions for research and clinical applications	$17.7M	Allumia Ventures, Philips Ventures & 3 others	39/100
6th	Coral Genomics 2018, San Francisco (United States), Seed	Provider of genomic data based drug development	$150K	Y Combinator, Hemisphere Ventures & 3 others	35/100
7th	AureumDx 2021, Glasgow (United Kingdom), Unfunded	Developer of electrochemical biosensing technology for redefining diagnostics	-	-	29/100
8th	Biomarx 2025, Belfast (United Kingdom), Seed	Developer of automated diagnostic systems for molecular testing at point of care	$942K	SFC Capital, Clarendon Fund Managers & 3 others	28/100
9th	BLINK 2015, Jena (Germany), Unfunded	Provider of point-of-care diagnostics tests	-	-	28/100
10th	VSense 2004, Israel, Funding Raised	Developer of semiconductor biosensor technology	-	UMC Capital, Acorn Campus Taiwan	27/100